Advancing Research with the goal of delivering life-changing solutions for people with MS.
More than 2.3 million people around the world live with multiple sclerosis (MS), an autoimmune, neuroinflammatory disease. Despite progress in our understanding of the disease, treating MS remains a challenge.
Celgene is committed to advancing research to deliver life-changing solutions for people with MS. Our teams and experts in the field share their excitement for what we’re doing now and what lies ahead for this complex disease and global community.
Advocacy & Collaboration
Celgene and our advocacy partners collaborate to bring hope to the fight against MS.
See a list of MS groups.
Celgene is committed to advancing research to change the lives of patients with MS.
Celgene is dedicated to offering support to patients with MS and those that care for them. Stay tuned for updates in the near future.